Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have ...

Taubes (@garytaubes), the bestselling author of Why We Get Fat and Good Calories, Bad Calories, is the author of the new book Rethinking Diabetes: What Science Reveals About Diet, Insulin, and ...

New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Recommendations for first-line therapy and comorbidities ...

Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a ...

Combination therapy with a nonsteroidal mineralocorticoid receptor antagonist and an SGLT2 inhibitor reduced albuminuria more ...

Groundbreaking research reveals that common blood sugar medications do more than manage glucose—they are actively reshaping ...

The U.S. Food and Drug Administration (FDA) recently approved the use of Teplizumab, a new, immunotherapy drug that has been shown to delay the onset of type 1 diabetes by at least two years. The drug ...

Analysis of the MarketScan database showed a strong association between flash continuous glucose monitoring (CGM) use and significant reductions in diabetes-related events and hospitalizations in a ...

Laser treatments are used to slow and stop the progression of diabetic retinopathy. These procedures aren’t painful, but they do require numbing drops beforehand ...